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Coronaviruses are single stranded RNA viruses found
throughout the world. The six well-known human
coronaviruses are 229E, OC43, NL63, HKU1, SARS-CoV1,2
and the most recently discovered Middle Eastern
Respiratory Syndrome coronavirus (MERS-CoV).
Coronaviruses, commonly associated with colds and
upper respiratory tract infections, are also known to cause
pneumonia in the elderly and immunocompromised
individuals.
The most well-known outbreak caused by a coronavirus in
recent times was the SARS outbreak (2002-2003) which
began in China and rapidly spread throughout the world
leading to about 8000 cases and 700 deaths.3 The origin
was later linked to bats which are commonly sold in
markets in China, primarily as food for civet cats, which in
turn serve as a delicacy for humans. With stringent
infection control measures worldwide, the outbreak was
eventually curtailed and there have been no new
reported cases after 2004. 
MERS-CoV-related illness was first recognized in early
2012. The origin of the virus however, remains
unknown. MERS-CoV virus is thought to be an animal
virus; humans are infected sporadically. The "alternative
explanation to explain the sporadic appearance of
severe human cases with long periods of time between
them, and the wide geographical area over which the
virus was apparently distributed, is unrecognized
ongoing transmission in people. Surveillance efforts
since the discovery of the virus and retrospective
testing of stored respiratory specimens suggest this is
not the case."4
The evidence for animal origin of the virus is
circumstantial and once again, bats are being
considered as the most likely source of MERS-CoV. The
virus has been placed in lineage C of the genus beta
coronavirus and is the only human virus in that group;
the other two members are bat coronaviruses.5,6 All
cases reported thus far have not been directly exposed
to bats raising the possibility of an intermediary host or
consumption of contaminated raw and unprocessed
food items, e.g. sun-dried fruits4 like dates and olives,
which are avidly consumed in the middle-east. Apart
from bats, rodents and domesticated animals like
camels, sheep, goats and household pets may serve as
sources of possible exposure for human cases and are a
subject of study.4
Viruses have been known to jump species, e.g the SARS
CoV, which jumped from bats to civet cats and then to
humans. For now however, the origin of MERS-CoV
remains unknown.
The first reported case of MERS-CoV infection was that
of a 60 year old male patient in Saudi Arabia who
became ill in June 2012 with fever, cough and dyspnea
and later died of respiratory and renal failure after
prolonged hospitalization.6 The virus was eventually
identified by cell culture and genome sequencing as a
novel coronavirus. Later, another case was reported
from Qatar7 with similar respiratory illness. This was
followed by a case cluster in a healthcare facility in
Jordan, which was reported retrospectively when some
of the saved respiratory samples were tested for MERS-
CoV.8 Since then, other case clusters have been
reported from Saudi Arabia,9 UK,10 France11 and
Tunisia12 with evidence of human — human
transmission after close contact. Some of these
infections were transmitted in healthcare facilities
either among patients who shared the same rooms,
family members visiting their ill relatives or healthcare
workers caring for these patients. All of the reported
cases have been either from the middle east or had a
history of recent travel to the region.
Clinical data that is available from the published case
reports reveals that most patients have had
predominantly respiratory symptoms, although atypical
presentation with diarrhoea has also been documented.
ARDS and renal failure are common complications
requiring intensive care. Common laboratory findings
have been lymphopenia, thrombocytopenia, rising
creatinine, and radiographic findings of either
consolidation or bilateral infiltrates consistent with ARDS.
Mean age of affected individuals has been 51 years
(varying from 2-94 years) and majority of the patients
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(65%) have been males.13 Many of the patients who
developed severe disease had multiple co-morbid
conditions or were immunocompromised either due to a
disease or medication. Mortality of MERS-CoV infection
has been high at approximately 56%; 45 of the 80
confirmed cases reported to-date have died.12 Although
this may be due to the fact that only severe cases have
been reported and patients with mild symptoms may not
have been diagnosed. 
Diagnosis of MERS-CoV infection can be confirmed by
reverse transcriptase PCR (RT-PCR) on respiratory, blood
and stool samples. Deep respiratory samples like sputum,
endotracheal aspirate and bronchial lavage are
recommended because of a higher yield.13 Of the
reported cases, nasopharyngeal swabs were negative in
many patients in whom deep respiratory samples were
found to be positive.10,11
The mode of transmission remains unknown but is most
likely to be by droplet transmission although airborne
transmission is also a possibility. Based on this and the fact
that there is a high morbidity and mortality associated
with this virus and currently no available effective
treatment, the WHO14 and CDC15 have jointly
recommended that suspected and confirmed cases
should be placed in airborne isolation rooms with limited
movement outside the room. However, where these
facilities are not available, healthcare workers should be
provided with a surgical face mask when entering the
patient's room and an N95 respirator to be used only for
aerosol generating procedures like endotracheal
intubation, nebulization, suctioning, tracheostomy,
bronchoscopy etc.14
Only limited human-human transmission has been
reported so far but since the first reported case, the
number of cases identified in the last several months
have increased with a relatively large cluster of 25 cases
reported from Saudi Arabia.16 When this virus achieve
the ability of sustained human-to-human transmission,
cannot be predicted with precision. What is evident is
the opportunity MERS-CoV (like any other less-well
adapted pathogen) will acquire during the huge
congregations in Ramadan and Hajj. Person-person
transmission, which is facilitated by close contact
among people from all parts of the world, makes the
threat of a pandemic, real. 
Until such a time that more information is available on
stability and transmission of MERS-CoV, healthcare
workers need to be vigilant especially when dealing with
patients returning from the middle eastern states and
those indigenous patients with respiratory symptoms
which are not responding to routine therapy. The
suspected cases should be identified and appropriate
infection control measures must be implemented to
limit transmission. Additionally, steps need to be taken
both by the medical community and at the government
level to increase awareness among the healthcare
workers about the symptoms, diagnostic criteria and
infection control measures. No effective anti-viral
treatment is available and management remains largely
supportive — a situation analogous to the SARS-CoV
infection. A non-commercial RT-PCR based diagnostic
test is currently available at limited facilities in Pakistan.
Every effort should be made to confirm the diagnosis in
suspected cases so that appropriate supportive and
infection control measures are instituted as early as
possible. 
The medical community has learned a lot from the SARS
epidemic which was contained - not by a vaccine and not
by antiviral therapy but by stringent infection control
measures. 
"The impact of any intervention depends on its efficiency
as well as efficacy."17 Exploring the possible impact of
quarantine, it was the progressive reduction in onset-to-
isolation intervals which eventually contributed to SARS
control.17
MERS-CoV is a highly pathogenic virus with a real
potential for causing outbreaks. However, at the moment
its ability for sustained transmission appears to be limited.
Applying the same principals of control as were used
during the SARS epidemic, it may yet be possible to
contain MERS-CoV close to its source of origin and thus
prevent a coronavirus pandemic.
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